EDIL3 Blocking Peptide for STJ500754 peptide (STJ503951)
SPECIFICATIONS
ImmunogenSynthetic peptide taken within amino acid region 30-60 on Del-1 protein.
General Information
| Short Description | EDIL3 Blocking Peptide for STJ500754 is synthetically produced from the 30-60 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Gene Symbol | Edil3 |
| Gene ID | 13612 |
| Uniprot ID | EDIL3_MOUSE |
| Immunogen | Synthetic peptide taken within amino acid region 30-60 on Del-1 protein. |
| Immunogen Region | 30-60 |
| Specificity | This blocking peptide is recommended for use in combination with EDIL3 antibody, STJ500754 |
Additional Info
| Tissue Specificity | Expressed in angioblasts and early endothelial cells. By embryonic day 13.5, also expressed in a restricted group of non-endothelial cells including chondrocytes and retinal neurons. |
| Function | Promotes adhesion of endothelial cells through interaction with the alpha-v/beta-3 integrin receptor. Inhibits formation of vascular-like structures. May be involved in regulation of vascular morphogenesis of remodeling in embryonic development. |
| Peptide Name | Egf-Like Repeat And Discoidin I-Like Domain-Containing Protein 3Developmentally-Regulated Endothelial Cell Locus 1 ProteinIntegrin-Binding Protein Del1 |
| Cellular Localisation | Secreted |
| Alternative Peptide Names | Egf-Like Repeat And Discoidin I-Like Domain-Containing Protein 3 proteinDevelopmentally-Regulated Endothelial Cell Locus 1 Protein proteinIntegrin-Binding Protein Del1 proteinEdil3 proteinDel1 protein |
Information sourced from Uniprot.org